{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:54:50Z","timestamp":1789692890467,"version":"4.0.1"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:00:00Z","timestamp":1773446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":48,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002661","name":"Fonds De La Recherche Scientifique - FNRS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001704","name":"European Society of Clinical Microbiology and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001704","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-026-09883-6","type":"journal-article","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T14:25:52Z","timestamp":1773498352000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Combinations of colistin and bacteriocins prevent the selection of colistin resistance in Acinetobacter baumannii"],"prefix":"10.1038","volume":"9","author":[{"given":"Tristan","family":"Rubio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"zur Nedden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safia","family":"Zedek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doroth\u00e9e","family":"Raoux-Bardot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6719-0402","authenticated-orcid":false,"given":"Calixte","family":"Cottineau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovic","family":"Belot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9ment","family":"Raynaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Oms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector","family":"Rodriguez-Vilallobos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1660-1524","authenticated-orcid":false,"given":"Dukas","family":"Jurenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4959-1003","authenticated-orcid":false,"given":"Alexandre","family":"Chenal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7778-1736","authenticated-orcid":false,"given":"Laurence","family":"Van Melderen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,14]]},"reference":[{"key":"9883_CR1","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00535-24","volume":"68","author":"V Gigante","year":"2024","unstructured":"Gigante, V. et al. Multi-year analysis of the global preclinical antibacterial pipeline: trends and gaps. Antimicrob. Agents Chemother. 68, e0053524 (2024).","journal-title":"Antimicrob. Agents Chemother."},{"key":"9883_CR2","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","volume":"404","author":"GBD 2021 Antimicrobial Resistance Collaborators","year":"2024","unstructured":"GBD 2021 Antimicrobial Resistance Collaborators Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050. Lancet 404, 1199\u20131226 (2024).","journal-title":"Lancet"},{"key":"9883_CR3","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"CJ Murray","year":"2022","unstructured":"Murray, C. J. et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 399, 629\u2013655 (2022).","journal-title":"Lancet"},{"key":"9883_CR4","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S1473-3099(25)00118-5","volume":"25","author":"H Sati","year":"2025","unstructured":"Sati, H. et al. The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance. Lancet Infect. Dis. 25, 1033\u20131043 (2025).","journal-title":"Lancet Infect. Dis."},{"key":"9883_CR5","doi-asserted-by":"crossref","unstructured":"M\u00fcller, C. et al. A global view on carbapenem-resistant Acinetobacter baumannii. mBio 14, e02260-23 (2023).","DOI":"10.1128\/mbio.02260-23"},{"key":"9883_CR6","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s40121-017-0149-y","volume":"6","author":"E Wenzler","year":"2017","unstructured":"Wenzler, E., Goff, D. A., Humphries, R. & Goldstein, E. J. C. Anticipating the unpredictable: a review of antimicrobial stewardship and acinetobacter infections. Infect. Dis. Ther. 6, 149\u2013172 (2017).","journal-title":"Infect. Dis. Ther."},{"key":"9883_CR7","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13756-024-01376-7","volume":"13","author":"N Bostanghadiri","year":"2024","unstructured":"Bostanghadiri, N. et al. Prevalence of colistin resistance in clinical isolates of Acinetobacter baumannii: a systematic review and meta-analysis. Antimicrob. Resist. Infect. Control 13, 24 (2024).","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"9883_CR8","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.bjm.2016.01.007","volume":"47","author":"YF Mohamed","year":"2016","unstructured":"Mohamed, Y. F., Abou-Shleib, H. M., Khalil, A. M., El-Guink, N. M. & El-Nakeeb, M. A. Membrane permeabilization of colistin toward pan-drug resistant Gram-negative isolates. Braz. J. Microbiol. 47, 381\u2013388 (2016).","journal-title":"Braz. J. Microbiol."},{"key":"9883_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7554\/eLife.65836","volume":"10","author":"A Sabnis","year":"2021","unstructured":"Sabnis, A. et al. Colistin kills bacteria by targeting lipopolysaccharide in the cytoplasmic membrane. eLife 10, 1\u201326 (2021).","journal-title":"eLife"},{"key":"9883_CR10","doi-asserted-by":"publisher","first-page":"965","DOI":"10.2147\/IDR.S199844","volume":"12","author":"Z Aghapour","year":"2019","unstructured":"Aghapour, Z. et al. Molecular mechanisms related to colistin resistance in Enterobacteriaceae. Infect. Drug Resist. 12, 965\u2013975 (2019).","journal-title":"Infect. Drug Resist."},{"key":"9883_CR11","doi-asserted-by":"publisher","first-page":"4971","DOI":"10.1128\/AAC.00834-10","volume":"54","author":"JH Moffatt","year":"2010","unstructured":"Moffatt, J. H. et al. Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production. Antimicrob. Agents Chemother. 54, 4971\u20134977 (2010).","journal-title":"Antimicrob. Agents Chemother."},{"key":"9883_CR12","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.1128\/AAC.01732-10","volume":"55","author":"JH Moffatt","year":"2011","unstructured":"Moffatt, J. H. et al. Insertion sequence ISAba11 is involved in colistin resistance and loss of lipopolysaccharide in Acinetobacter baumannii. Antimicrob. Agents Chemother. 55, 3022\u20133024 (2011).","journal-title":"Antimicrob. Agents Chemother."},{"key":"9883_CR13","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.ijantimicag.2017.01.031","volume":"49","author":"E Dahdouh","year":"2017","unstructured":"Dahdouh, E. et al. A novel mutation in pmrB mediates colistin resistance during therapy of Acinetobacter baumannii. Int J. Antimicrob. Agents 49, 727\u2013733 (2017).","journal-title":"Int J. Antimicrob. Agents"},{"key":"9883_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-25226-x","volume":"12","author":"SM Seleim","year":"2022","unstructured":"Seleim, S. M., Mostafa, M. S., Ouda, N. H. & Shash, R. Y. The role of pmrCAB genes in colistin-resistant Acinetobacter baumannii. Sci. Rep. 12, 20951 (2022).","journal-title":"Sci. Rep."},{"key":"9883_CR15","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/s12275-017-6408-5","volume":"55","author":"M-F Lin","year":"2017","unstructured":"Lin, M.-F., Lin, Y.-Y. & Lan, C.-Y. Contribution of EmrAB efflux pumps to colistin resistance in Acinetobacter baumannii. J. Microbiol. 55, 130\u2013136 (2017).","journal-title":"J. Microbiol."},{"key":"9883_CR16","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41579-018-0141-x","volume":"17","author":"M Tyers","year":"2019","unstructured":"Tyers, M. & Wright, G. D. Drug combinations: a strategy to extend the life of antibiotics in the 21st century. Nat. Rev. Microbiol. 17, 141\u2013155 (2019).","journal-title":"Nat. Rev. Microbiol."},{"key":"9883_CR17","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.diagmicrobio.2010.12.023","volume":"70","author":"RK Shields","year":"2011","unstructured":"Shields, R. K. et al. High mortality rates among solid organ transplant recipients infected with extensively drug-resistant Acinetobacter baumannii: using in vitro antibiotic combination testing to identify the combination of a carbapenem and colistin as an effective treatment regimen. Diagn. Microbiol Infect. Dis. 70, 246\u2013252 (2011).","journal-title":"Diagn. Microbiol Infect. Dis."},{"key":"9883_CR18","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1476-0711-5-10","volume":"5","author":"DW Wareham","year":"2006","unstructured":"Wareham, D. W. & Bean, D. C. In-vitro activity of polymyxin B in combination with imipenem, rifampicin and azithromycin versus multidrug resistant strains of Acinetobacter baumannii producing OXA-23 carbapenemases. Ann. Clin. Microbiol. Antimicrob. 5, 10 (2006).","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"9883_CR19","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1128\/AAC.00689-07","volume":"52","author":"GA Pankuch","year":"2008","unstructured":"Pankuch, G. A., Lin, G., Seifert, H. & Appelbaum, P. C. Activity of meropenem with and without ciprofloxacin and colistin against Pseudomonas aeruginosa and Acinetobacter baumannii. Antimicrob. Agents Chemother. 52, 333\u2013336 (2008).","journal-title":"Antimicrob. Agents Chemother."},{"key":"9883_CR20","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1179\/joc.2008.20.2.180","volume":"20","author":"KC Guelfi","year":"2008","unstructured":"Guelfi, K. C. et al. In vitro evaluation of the antimicrobial activity of meropenem in combination with polymyxin B and gatifloxacin against Pseudomonas aeruginosa and Acinetobacter baumannii. J. Chemother. 20, 180\u2013185 (2008).","journal-title":"J. Chemother."},{"key":"9883_CR21","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1080\/22221751.2021.2002671","volume":"10","author":"X Wang","year":"2021","unstructured":"Wang, X. et al. Colistin-phage combinations decrease antibiotic resistance in Acinetobacter baumannii via changes in envelope architecture. Emerg. Microbes Infect. 10, 2205\u20132219 (2021).","journal-title":"Emerg. Microbes Infect."},{"key":"9883_CR22","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41579-024-01045-x","volume":"22","author":"I Sugrue","year":"2024","unstructured":"Sugrue, I., Ross, R. P. & Hill, C. Bacteriocin diversity, function, discovery and application as antimicrobials. Nat. Rev. Microbiol. 22, 556\u2013571 (2024).","journal-title":"Nat. Rev. Microbiol."},{"key":"9883_CR23","doi-asserted-by":"publisher","DOI":"10.1093\/femsre\/fuaa039","volume":"45","author":"S Soltani","year":"2021","unstructured":"Soltani, S. et al. Bacteriocins as a new generation of antimicrobials: toxicity aspects and regulations. FEMS Microbiol. Rev. 45, fuaa039 (2021).","journal-title":"FEMS Microbiol. Rev."},{"key":"9883_CR24","doi-asserted-by":"publisher","first-page":"586433","DOI":"10.3389\/fmicb.2020.586433","volume":"11","author":"S Telhig","year":"2020","unstructured":"Telhig, S., Ben Said, L., Zirah, S., Fliss, I. & Rebuffat, S. Bacteriocins to Thwart Sbacterial resistance in gram negative bacteria. Front. Microbiol. 11, 586433 (2020).","journal-title":"Front. Microbiol."},{"key":"9883_CR25","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nrmicro2937","volume":"11","author":"PD Cotter","year":"2013","unstructured":"Cotter, P. D., Ross, R. P. & Hill, C. Bacteriocins - A viable alternative to antibiotics? Nat. Rev. Microbiol 11, 95\u2013105 (2013).","journal-title":"Nat. Rev. Microbiol"},{"key":"9883_CR26","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1128\/AAC.02328-12","volume":"57","author":"K Naghmouchi","year":"2013","unstructured":"Naghmouchi, K. et al. Synergistic effect between colistin and bacteriocins in controlling Gram-negative pathogens and their potential to reduce antibiotic toxicity in mammalian epithelial cells. Antimicrob. Agents Chemother. 57, 2719\u20132725 (2013).","journal-title":"Antimicrob. Agents Chemother."},{"key":"9883_CR27","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/s00284-017-1375-y","volume":"75","author":"H Chi","year":"2018","unstructured":"Chi, H. & Holo, H. Synergistic antimicrobial activity between the broad spectrum bacteriocin garvicin KS and nisin, farnesol and polymyxin B against gram-positive and gram-negative bacteria. Curr. Microbiol. 75, 272\u2013277 (2018).","journal-title":"Curr. Microbiol."},{"key":"9883_CR28","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.ijantimicag.2019.03.009","volume":"53","author":"VM Thomas","year":"2019","unstructured":"Thomas, V. M., Brown, R. M., Ashcraft, D. S. & Pankey, G. A. Synergistic effect between nisin and polymyxin B against pandrug-resistant and extensively drug-resistant Acinetobacter baumannii. Int. J. Antimicrob. Agents 53, 663\u2013668 (2019).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"9883_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2020.104700","volume":"150","author":"A Jahangiri","year":"2021","unstructured":"Jahangiri, A. et al. Synergistic effect of two antimicrobial peptides, Nisin and P10 with conventional antibiotics against extensively drug-resistant Acinetobacter baumannii and colistin-resistant Pseudomonas aeruginosa isolates. Micro. Pathog. 150, 104700 (2021).","journal-title":"Micro. Pathog."},{"key":"9883_CR30","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1093\/jac\/dkx395","volume":"73","author":"C Brunati","year":"2018","unstructured":"Brunati, C. et al. Expanding the potential of NAI-107 for treating serious ESKAPE pathogens: synergistic combinations against Gram-negatives and bactericidal activity against non-dividing cells. J. Antimicrob. Chemother. 73, 414\u2013424 (2018).","journal-title":"J. Antimicrob. Chemother."},{"key":"9883_CR31","doi-asserted-by":"publisher","first-page":"RP102912","DOI":"10.7554\/eLife.102912.2","volume":"13","author":"BM Mortzfeld","year":"2024","unstructured":"Mortzfeld, B. M., Bhattarai, S. K. & Bucci, V. Novel class IIb microcins show activity against Gram-negative ESKAPE and plant pathogens. Elife 13, RP102912 (2024).","journal-title":"Elife"},{"key":"9883_CR32","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.03061-22","volume":"11","author":"A Valcek","year":"2023","unstructured":"Valcek, A. et al. Phenotypic Characterization and Heterogeneity among Modern Clinical Isolates of Acinetobacter baumannii. Microbiol. Spectr. 11, e0306122 (2023).","journal-title":"Microbiol. Spectr."},{"key":"9883_CR33","doi-asserted-by":"crossref","unstructured":"Jacobs, A. C. et al. AB5075, a highly virulent isolate of acinetobacter baumannii, as a model strain for the evaluation of pathogenesis and antimicrobial treatments. mBio 5, 10\u20131128 (2014).","DOI":"10.1128\/mBio.01076-14"},{"key":"9883_CR34","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3390\/antibiotics9030119","volume":"9","author":"C Ayoub Moubareck","year":"2020","unstructured":"Ayoub Moubareck, C. & Hammoudi Halat, D. Insights into acinetobacter baumannii: a review of microbiological, virulence, and resistance traits in a threatening nosocomial pathogen. Antibiotics 9, 119 (2020).","journal-title":"Antibiotics"},{"key":"9883_CR35","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1271\/bbb.70169","volume":"71","author":"S Iwatani","year":"2007","unstructured":"Iwatani, S., Zendo, T., Yoneyama, F., Nakayama, J. & Sonomoto, K. Characterization and structure analysis of a novel bacteriocin, lacticin Z, produced by Lactococcus lactis QU 14. Biosci. Biotechnol. Biochem. 71, 1984\u20131992 (2007).","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"9883_CR36","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1128\/JB.180.8.1988-1994.1998","volume":"180","author":"LM Cintas","year":"1998","unstructured":"Cintas, L. M. et al. Enterocins L50A and L50B, two novel bacteriocins from Enterococcus faecium L50, are related to staphylococcal hemolysins. J. Bacteriol. 180, 1988\u20131994 (1998).","journal-title":"J. Bacteriol."},{"key":"9883_CR37","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1128\/AAC.00808-10","volume":"55","author":"F Yoneyama","year":"2011","unstructured":"Yoneyama, F. et al. Lacticin Q-mediated selective toxicity depending on physicochemical features of membrane components. Antimicrob. Agents Chemother. 55, 2446\u20132450 (2011).","journal-title":"Antimicrob. Agents Chemother."},{"key":"9883_CR38","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02825-23","volume":"11","author":"N Hofkens","year":"2023","unstructured":"Hofkens, N. et al. Microbisporicin (NAI-107) protects Galleria mellonella from infection with Neisseria gonorrhoeae. Microbiol. Spectr. 11, e0282523 (2023).","journal-title":"Microbiol. Spectr."},{"key":"9883_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-55262-8","volume":"14","author":"N Hofkens","year":"2024","unstructured":"Hofkens, N. et al. Protective effect of microbisporicin (NAI-107) against vancomycin resistant Enterococcus faecium infection in a Galleria mellonella model. Sci. Rep. 14, 4786 (2024).","journal-title":"Sci. Rep."},{"key":"9883_CR40","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1128\/AEM.02286-06","volume":"73","author":"K Fujita","year":"2007","unstructured":"Fujita, K. et al. Structural analysis and characterization of lacticin Q, a novel bacteriocin belonging to a new family of unmodified bacteriocins of gram-positive bacteria. Appl. Environ. Microbiol. 73, 2871\u20132877 (2007).","journal-title":"Appl. Environ. Microbiol."},{"key":"9883_CR41","doi-asserted-by":"publisher","first-page":"5602","DOI":"10.1021\/jf104751v","volume":"59","author":"X Liu","year":"2011","unstructured":"Liu, X. et al. Identification of an N-terminal formylated, two-peptide bacteriocin from Enterococcus faecalis 710C. J. Agric. Food Chem. 59, 5602\u20135608 (2011).","journal-title":"J. Agric. Food Chem."},{"key":"9883_CR42","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","volume":"630","author":"J Abramson","year":"2024","unstructured":"Abramson, J. et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630, 493\u2013500 (2024).","journal-title":"Nature"},{"key":"9883_CR43","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1021\/acs.biochem.5b01306","volume":"55","author":"JZ Acedo","year":"2016","unstructured":"Acedo, J. Z. et al. Nuclear magnetic resonance solution structures of lacticin Q and aureocin A53 reveal a structural motif conserved among leaderless bacteriocins with broad-spectrum activity. Biochemistry 55, 733\u2013742 (2016).","journal-title":"Biochemistry"},{"key":"9883_CR44","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1128\/AEM.01827-08","volume":"75","author":"F Yoneyama","year":"2009","unstructured":"Yoneyama, F. et al. Lacticin Q, a lactococcal bacteriocin, causes high-level membrane permeability in the absence of specific receptors. Appl. Environ. Microbiol 75, 538\u2013541 (2009).","journal-title":"Appl. Environ. Microbiol"},{"key":"9883_CR45","doi-asserted-by":"publisher","first-page":"3211","DOI":"10.1128\/AAC.00209-09","volume":"53","author":"F Yoneyama","year":"2009","unstructured":"Yoneyama, F. et al. Peptide-lipid huge toroidal pore, a new antimicrobial mechanism mediated by a lactococcal bacteriocin, lacticin Q. Antimicrob. Agents Chemother. 53, 3211\u20133217 (2009).","journal-title":"Antimicrob. Agents Chemother."},{"key":"9883_CR46","doi-asserted-by":"publisher","first-page":"5274","DOI":"10.1128\/AEM.68.11.5274-5280.2002","volume":"68","author":"DJA Netz","year":"2002","unstructured":"Netz, D. J. A., Bastos, M., do, C., de, F. & Sahl, H.-G. Mode of action of the antimicrobial peptide aureocin A53 from Staphylococcus aureus. Appl. Environ. Microbiol. 68, 5274\u20135280 (2002).","journal-title":"Appl. Environ. Microbiol."},{"key":"9883_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-03214-w","volume":"7","author":"P Lopalco","year":"2017","unstructured":"Lopalco, P., Stahl, J., Annese, C., Averhoff, B. & Corcelli, A. Identification of unique cardiolipin and monolysocardiolipin species in Acinetobacter baumannii. Sci. Rep. 7, 2972 (2017).","journal-title":"Sci. Rep."},{"key":"9883_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2020.115964","volume":"30","author":"F Ushiyama","year":"2021","unstructured":"Ushiyama, F. et al. Lead optimization of 2-hydroxymethyl imidazoles as non-hydroxamate LpxC inhibitors: discovery of TP0586532. Bioorg. Med. Chem. 30, 115964 (2021).","journal-title":"Bioorg. Med. Chem."},{"key":"9883_CR49","doi-asserted-by":"publisher","first-page":"e0082822","DOI":"10.1128\/spectrum.00828-22","volume":"10","author":"I Yoshida","year":"2022","unstructured":"Yoshida, I., Takata, I., Fujita, K., Takashima, H. & Sugiyama, H. TP0586532, a novel non-hydroxamate LpxC inhibitor: potentiating effect on in vitro activity of meropenem against carbapenem-resistant Enterobacteriaceae. Microbiol. Spectr. 10, e0082822 (2022).","journal-title":"Microbiol. Spectr."},{"key":"9883_CR50","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.03099-21","volume":"12","author":"BW Simpson","year":"2021","unstructured":"Simpson, B. W. et al. Acinetobacter baumannii can survive with an outer membrane lacking lipooligosaccharide due to structural support from elongasome peptidoglycan synthesis. mBio 12, e0309921 (2021).","journal-title":"mBio"},{"key":"9883_CR51","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1080\/21505594.2018.1460187","volume":"9","author":"M Carretero-Ledesma","year":"2018","unstructured":"Carretero-Ledesma, M. et al. Phenotypic changes associated with Colistin resistance due to Lipopolysaccharide loss in Acinetobacter baumannii. Virulence 9, 930\u2013942 (2018).","journal-title":"Virulence"},{"key":"9883_CR52","doi-asserted-by":"publisher","first-page":"573","DOI":"10.3389\/fmicb.2020.00573","volume":"11","author":"G Kamoshida","year":"2020","unstructured":"Kamoshida, G. et al. Lipopolysaccharide-deficient Acinetobacter baumannii due to colistin resistance is killed by neutrophil-produced lysozyme. Front. Microbiol. 11, 573 (2020).","journal-title":"Front. Microbiol."},{"key":"9883_CR53","doi-asserted-by":"publisher","first-page":"E8518","DOI":"10.1073\/pnas.1806714115","volume":"115","author":"MJ Powers","year":"2018","unstructured":"Powers, M. J. & Trent, M. S. Phospholipid retention in the absence of asymmetry strengthens the outer membrane permeability barrier to last-resort antibiotics. Proc. Natl. Acad. Sci. USA 115, E8518\u2013E8527 (2018).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"9883_CR54","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1128\/AAC.01597-13","volume":"58","author":"A Beceiro","year":"2014","unstructured":"Beceiro, A. et al. Biological cost of different mechanisms of colistin resistance and their impact on virulence in Acinetobacter baumannii. Antimicrob. Agents Chemother. 58, 518\u2013526 (2014).","journal-title":"Antimicrob. Agents Chemother."},{"key":"9883_CR55","doi-asserted-by":"publisher","first-page":"E6228","DOI":"10.1073\/pnas.1611594113","volume":"113","author":"JM Boll","year":"2016","unstructured":"Boll, J. M. et al. A penicillin-binding protein inhibits selection of colistin-resistant, lipooligosaccharide-deficient Acinetobacter baumannii. Proc. Natl. Acad. Sci. USA 113, E6228\u2013E6237 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"9883_CR56","doi-asserted-by":"publisher","first-page":"e2515303123","DOI":"10.1073\/pnas.2515303123","volume":"123","author":"J Hernandez-Bird","year":"2026","unstructured":"Hernandez-Bird, J. et al. Resistance, heteroresistance, and fitness costs drive colistin treatment failure during Acinetobacter baumannii pneumonia. Proc. Natl. Acad. Sci. USA 123, e2515303123 (2026).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"9883_CR57","doi-asserted-by":"publisher","first-page":"e00788","DOI":"10.1128\/AAC.00788-18","volume":"62","author":"Y Charretier","year":"2018","unstructured":"Charretier, Y. et al. Colistin heteroresistance and involvement of the PmrAB regulatory system in Acinetobacter baumannii. Antimicrob. Agents Chemother. 62, e00788\u201318 (2018).","journal-title":"Antimicrob. Agents Chemother."},{"key":"9883_CR58","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.jinf.2008.11.002","volume":"58","author":"W Yau","year":"2009","unstructured":"Yau, W. et al. Colistin hetero-resistance in multidrug-resistant Acinetobacter baumannii clinical isolates from the Western Pacific region in the SENTRY antimicrobial surveillance programme. J. Infect. 58, 138\u2013144 (2009).","journal-title":"J. Infect."},{"key":"9883_CR59","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/s41579-019-0218-1","volume":"17","author":"DI Andersson","year":"2019","unstructured":"Andersson, D. I., Nicoloff, H. & Hjort, K. Mechanisms and clinical relevance of bacterial heteroresistance. Nat. Rev. Microbiol 17, 479\u2013496 (2019).","journal-title":"Nat. Rev. Microbiol"},{"key":"9883_CR60","doi-asserted-by":"publisher","first-page":"516","DOI":"10.3390\/antibiotics12030516","volume":"12","author":"K Novovi\u0107","year":"2023","unstructured":"Novovi\u0107, K. & Jov\u010di\u0107, B. Colistin resistance in Acinetobacter baumannii: molecular mechanisms and epidemiology. Antibiotics 12, 516 (2023).","journal-title":"Antibiotics"},{"key":"9883_CR61","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01627-24","volume":"69","author":"B Veeraraghavan","year":"2025","unstructured":"Veeraraghavan, B. et al. A microbiological and structural analysis of the interplay between sulbactam\/durlobactam and imipenem against penicillin-binding proteins (PBPs) of Acinetobacter spp. Antimicrob. Agents Chemother. 69, e0162724 (2025).","journal-title":"Antimicrob. Agents Chemother."},{"key":"9883_CR62","doi-asserted-by":"publisher","first-page":"394","DOI":"10.7164\/antibiotics.37.394","volume":"37","author":"T Hashizume","year":"1984","unstructured":"Hashizume, T., Ishino, F., Nakagawa, J., Tamaki, S. & Matsuhashi, M. Studies on the mechanism of action of imipenem (N-formimidoylthienamycin) in vitro: binding to the penicillin-binding proteins (PBPs) in Escherichia coli and Pseudomonas aeruginosa, and inhibition of enzyme activities due to the PBPs in E. coli. J. Antibiot. 37, 394\u2013400 (1984).","journal-title":"J. Antibiot."},{"key":"9883_CR63","doi-asserted-by":"publisher","first-page":"646","DOI":"10.3389\/fmicb.2019.00646","volume":"10","author":"I Atanaskovic","year":"2019","unstructured":"Atanaskovic, I. & Kleanthous, C. Tools and approaches for dissecting protein bacteriocin import in gram-negative bacteria. Front. Microbiol. 10, 646 (2019).","journal-title":"Front. Microbiol."},{"key":"9883_CR64","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.tim.2004.04.002","volume":"12","author":"O Tenaillon","year":"2004","unstructured":"Tenaillon, O., Denamur, E. & Matic, I. Evolutionary significance of stress-induced mutagenesis in bacteria. Trends Microbiol. 12, 264\u2013270 (2004).","journal-title":"Trends Microbiol."},{"key":"9883_CR65","doi-asserted-by":"publisher","first-page":"e0107422","DOI":"10.1128\/mbio.01074-22","volume":"13","author":"JP Pribis","year":"2022","unstructured":"Pribis, J. P., Zhai, Y., Hastings, P. J. & Rosenberg, S. M. Stress-induced mutagenesis, gambler cells, and stealth targeting antibiotic-induced evolution. mBio 13, e0107422 (2022).","journal-title":"mBio"},{"key":"9883_CR66","doi-asserted-by":"publisher","first-page":"e3001194","DOI":"10.1371\/journal.pbio.3001194","volume":"19","author":"S Manuse","year":"2021","unstructured":"Manuse, S. et al. Bacterial persisters are a stochastically formed subpopulation of low-energy cells. PLoS Biol. 19, e3001194 (2021).","journal-title":"PLoS Biol."},{"key":"9883_CR67","doi-asserted-by":"publisher","first-page":"e02267","DOI":"10.1128\/mBio.02267-16","volume":"8","author":"Y Shan","year":"2017","unstructured":"Shan, Y. et al. ATP-dependent persister formation in Escherichia coli. mBio 8, e02267\u201316 (2017).","journal-title":"mBio"},{"key":"9883_CR68","doi-asserted-by":"publisher","first-page":"871699","DOI":"10.3389\/fmicb.2022.871699","volume":"13","author":"D Edelmann","year":"2022","unstructured":"Edelmann, D. & Berghoff, B. A. A shift in perspective: a role for the type I toxin TisB as persistence-stabilizing factor. Front. Microbiol. 13, 871699 (2022).","journal-title":"Front. Microbiol."},{"key":"9883_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-02875-z","volume":"9","author":"CR MacNair","year":"2018","unstructured":"MacNair, C. R. et al. Overcoming mcr-1 mediated colistin resistance with colistin in combination with other antibiotics. Nat. Commun. 9, 458 (2018).","journal-title":"Nat. Commun."},{"key":"9883_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56934-3","volume":"16","author":"E Maharramov","year":"2025","unstructured":"Maharramov, E. et al. Exploring the principles behind antibiotics with limited resistance. Nat. Commun. 16, 1842 (2025).","journal-title":"Nat. Commun."},{"key":"9883_CR71","doi-asserted-by":"publisher","first-page":"4834","DOI":"10.1096\/fj.13-237610","volume":"27","author":"G Kaneti","year":"2013","unstructured":"Kaneti, G., Sarig, H., Marjieh, I., Fadia, Z. & Mor, A. Simultaneous breakdown of multiple antibiotic resistance mechanisms in S. aureus. FASEB J. 27, 4834\u20134843 (2013).","journal-title":"FASEB J."},{"key":"9883_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/nmicrobiol.2017.28","volume":"2","author":"JM Stokes","year":"2017","unstructured":"Stokes, J. M. et al. Pentamidine sensitizes Gram-negative pathogens to antibiotics and overcomes acquired colistin resistance. Nat. Microbiol 2, 17028 (2017).","journal-title":"Nat. Microbiol"},{"key":"9883_CR73","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/s41564-018-0164-0","volume":"3","author":"V L\u00e1z\u00e1r","year":"2018","unstructured":"L\u00e1z\u00e1r, V. et al. Antibiotic-resistant bacteria show widespread collateral sensitivity to antimicrobial peptides. Nat. Microbiol 3, 718\u2013731 (2018).","journal-title":"Nat. Microbiol"},{"key":"9883_CR74","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1126\/science.277.5331.1453","volume":"277","author":"FR Blattner","year":"1997","unstructured":"Blattner, F. R. et al. The complete genome sequence of Escherichia coli K-12. Science 277, 1453\u20131462 (1997).","journal-title":"Science"},{"key":"9883_CR75","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3389\/fbioe.2019.00213","volume":"7","author":"P Gabant","year":"2019","unstructured":"Gabant, P. & Borrero, J. PARAGEN 1.0: a standardized synthetic gene library for fast cell-free bacteriocin synthesis. Front Bioeng. Biotechnol. 7, 213 (2019).","journal-title":"Front Bioeng. Biotechnol."},{"key":"9883_CR76","doi-asserted-by":"publisher","first-page":"E8396","DOI":"10.1073\/pnas.1604560113","volume":"113","author":"Y Lin","year":"2016","unstructured":"Lin, Y. et al. Assembly of long error-prone reads using de Bruijn graphs. Proc. Natl. Acad. Sci. USA 113, E8396\u2013E8405 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"9883_CR77","doi-asserted-by":"publisher","first-page":"3210","DOI":"10.1093\/bioinformatics\/btv351","volume":"31","author":"FA Sim\u00e3o","year":"2015","unstructured":"Sim\u00e3o, F. A., Waterhouse, R. M., Ioannidis, P., Kriventseva, E. V. & Zdobnov, E. M. BUSCO: assessing genome assembly and annotation completeness with single-copy orthologs. Bioinformatics 31, 3210\u20133212 (2015).","journal-title":"Bioinformatics"},{"key":"9883_CR78","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1093\/bioinformatics\/btu135","volume":"30","author":"G Cuccuru","year":"2014","unstructured":"Cuccuru, G. et al. Orione, a web-based framework for NGS analysis in microbiology. Bioinformatics 30, 1928\u20131929 (2014).","journal-title":"Bioinformatics"},{"key":"9883_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-91456-0","volume":"11","author":"M Feldgarden","year":"2021","unstructured":"Feldgarden, M. et al. AMRFinderPlus and the Reference Gene Catalog facilitate examination of the genomic links among antimicrobial resistance, stress response, and virulence. Sci. Rep. 11, 12728 (2021).","journal-title":"Sci. Rep."},{"key":"9883_CR80","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1093\/nar\/gkx1321","volume":"46","author":"PS Krawczyk","year":"2018","unstructured":"Krawczyk, P. S., Lipinski, L. & Dziembowski, A. PlasFlow: predicting plasmid sequences in metagenomic data using genome signatures. Nucleic Acids Res 46, e35 (2018).","journal-title":"Nucleic Acids Res"},{"key":"9883_CR81","doi-asserted-by":"crossref","first-page":"lqaa106","DOI":"10.1093\/nargab\/lqab106","volume":"3","author":"A Perrin","year":"2021","unstructured":"Perrin, A. & Rocha, E. P. C. PanACoTA: a modular tool for massive microbial comparative genomics. NAR Genom. Bioinform. 3, lqaa106 (2021).","journal-title":"NAR Genom. Bioinform."},{"key":"9883_CR82","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1093\/jac\/dkaf332","volume":"80","author":"I Morrissey","year":"2025","unstructured":"Morrissey, I. & Patel, J. B. Modification of antimicrobial susceptibility testing methods. J. Antimicrob. Chemother. 80, 2887\u20132888 (2025).","journal-title":"J. Antimicrob. Chemother."},{"key":"9883_CR83","doi-asserted-by":"publisher","DOI":"10.1038\/srep42065","volume":"7","author":"SE Cannella","year":"2017","unstructured":"Cannella, S. E. et al. Stability, structural and functional properties of a monomeric, calcium-loaded adenylate cyclase toxin, CyaA, from Bordetella pertussis. Sci. Rep. 7, 42065 (2017).","journal-title":"Sci. Rep."},{"key":"9883_CR84","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202003630","volume":"8","author":"A Voegele","year":"2021","unstructured":"Voegele, A. et al. A high-affinity calmodulin-binding site in the CyaA toxin translocation domain is essential for invasion of eukaryotic cells. Adv. Sci. 8, 2003630 (2021).","journal-title":"Adv. Sci."},{"key":"9883_CR85","doi-asserted-by":"publisher","first-page":"32585","DOI":"10.1074\/jbc.M113.508838","volume":"288","author":"O Subrini","year":"2013","unstructured":"Subrini, O. et al. Characterization of a membrane-active peptide from the Bordetella pertussis CyaA toxin. J. Biol. Chem. 288, 32585\u201332598 (2013).","journal-title":"J. Biol. Chem."},{"key":"9883_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.crmeth.2023.100624","volume":"3","author":"M Sadi","year":"2023","unstructured":"Sadi, M. et al. B2LiVe, a label-free 1D-NMR method to quantify the binding of amphitropic peptides or proteins to membrane vesicles. Cell Rep. Methods 3, 100624 (2023).","journal-title":"Cell Rep. Methods"}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09883-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09883-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09883-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T11:02:34Z","timestamp":1777633354000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09883-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,14]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9883"],"URL":"https:\/\/doi.org\/10.1038\/s42003-026-09883-6","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,14]]},"assertion":[{"value":"12 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"599"}}